<DOC>
	<DOCNO>NCT00660309</DOCNO>
	<brief_summary>The study objective ass effect single multiple dos aliskiren renal plasma flow , glomerular filtration rate compare effect single multiple dos aliskiren versus captopril irbesartan renal blood flow , glomerular filtration rate , retinal blood flow patient type 2 diabetes mellitus .</brief_summary>
	<brief_title>A Clinical Study Evaluate Renal Hemodynamic Responses Aliskiren Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Irbesartan</mesh_term>
	<mesh_term>Captopril</mesh_term>
	<criteria>Hypertensive , male female nonchild bear potential patient , type 2 diabetes mellitus ( T2DM ) ( diagnose least 8 week Screening ) , without renal impairment ; estimate glomerular filtration rate ( eGFR ) â‰¥ 40 mL/min/1.73 m^2 , document least 3 month study start , aged 1875 year minimum body weight 50 kg appropriate intravenous access determine study staff , able communicate well enrol study . Patients must stable dose hypoglycemic medication least 8 week prior study . Patients must medically able discontinue anti hypertensive medication duration study . Patients type 1 diabetes mellitus uncontrolled T2DM ( HbA1C &gt; 11 % ) , eGFR &lt; 40 mL/min/1.73 m^2 ( calculated Modification Diet Renal Disease ( MDRD ) formula ) , renal disease cause diabetes hypertension , serum potassium &lt; 3.5 &gt; 5.1 mEq/L , heart failure ( New York Heart Association ( NYHA ) Class IIIV ) history acute/decompensated heart failure within 6 month prior dose , history myocardial infarction , unstable angina pectoris , coronary bypass surgery , percutaneous coronary intervention ( PCI ) 6 month prior baseline visit , history malignancy include leukemia lymphoma within past five year , hypertensive encephalopathy time past cerebrovascular accident within 6 month prior baseline visit , history drug alcohol abuse within 12 month prior dose exclude study . Patients glaucoma , prior ocular surgery . Patients renal disease cause diabetes hypertension . Patients history clinically significant drug atopic allergy , acute chronic respiratory disease , history malignancy , history myocardial infarction , unstable angina pectoris , coronary bypass surgery , coronary intervention ( percutaneous coronary intervention ; PCI ) 6 month prior study . Patients used prescription drug may affect reninangiotensinaldosterone system know effect renal hemodynamics within 2 week prior dose study , overthecounter ( OTC ) medication within two ( 2 ) week prior dose , Any surgical medical condition may jeopardize patient case participation study . Participation clinical investigation within 4 week prior study . Donation loss 400 mL blood within 8 week prior study . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>renal disease</keyword>
	<keyword>hypertension</keyword>
	<keyword>renal blood flow</keyword>
	<keyword>retinal blood flow</keyword>
	<keyword>aliskiren</keyword>
	<keyword>irbesartan</keyword>
	<keyword>captopril</keyword>
</DOC>